IBDEI0VE ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15252,2)
 ;;=^336547
 ;;^UTILITY(U,$J,358.3,15253,0)
 ;;=339.04^^81^941^64
 ;;^UTILITY(U,$J,358.3,15253,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15253,1,4,0)
 ;;=4^339.04
 ;;^UTILITY(U,$J,358.3,15253,1,5,0)
 ;;=5^Hemicrania,Paroxysmal,Chr
 ;;^UTILITY(U,$J,358.3,15253,2)
 ;;=^336548
 ;;^UTILITY(U,$J,358.3,15254,0)
 ;;=339.05^^81^941^57
 ;;^UTILITY(U,$J,358.3,15254,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15254,1,4,0)
 ;;=4^339.05
 ;;^UTILITY(U,$J,358.3,15254,1,5,0)
 ;;=5^Headache,SUNCT
 ;;^UTILITY(U,$J,358.3,15254,2)
 ;;=^336549
 ;;^UTILITY(U,$J,358.3,15255,0)
 ;;=339.10^^81^941^62
 ;;^UTILITY(U,$J,358.3,15255,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15255,1,4,0)
 ;;=4^339.10
 ;;^UTILITY(U,$J,358.3,15255,1,5,0)
 ;;=5^Headache,Tension NOS
 ;;^UTILITY(U,$J,358.3,15255,2)
 ;;=^336742
 ;;^UTILITY(U,$J,358.3,15256,0)
 ;;=339.11^^81^941^61
 ;;^UTILITY(U,$J,358.3,15256,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15256,1,4,0)
 ;;=4^339.11
 ;;^UTILITY(U,$J,358.3,15256,1,5,0)
 ;;=5^Headache,Tension Episodic
 ;;^UTILITY(U,$J,358.3,15256,2)
 ;;=^336551
 ;;^UTILITY(U,$J,358.3,15257,0)
 ;;=339.12^^81^941^60
 ;;^UTILITY(U,$J,358.3,15257,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15257,1,4,0)
 ;;=4^339.12
 ;;^UTILITY(U,$J,358.3,15257,1,5,0)
 ;;=5^Headache,Tension Chr
 ;;^UTILITY(U,$J,358.3,15257,2)
 ;;=^336552
 ;;^UTILITY(U,$J,358.3,15258,0)
 ;;=339.20^^81^941^52
 ;;^UTILITY(U,$J,358.3,15258,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15258,1,4,0)
 ;;=4^339.20
 ;;^UTILITY(U,$J,358.3,15258,1,5,0)
 ;;=5^Headache,Post-Traumatic NOS
 ;;^UTILITY(U,$J,358.3,15258,2)
 ;;=^336743
 ;;^UTILITY(U,$J,358.3,15259,0)
 ;;=339.21^^81^941^50
 ;;^UTILITY(U,$J,358.3,15259,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15259,1,4,0)
 ;;=4^339.21
 ;;^UTILITY(U,$J,358.3,15259,1,5,0)
 ;;=5^Headache,Post-Traumatic Acute
 ;;^UTILITY(U,$J,358.3,15259,2)
 ;;=^336553
 ;;^UTILITY(U,$J,358.3,15260,0)
 ;;=339.22^^81^941^51
 ;;^UTILITY(U,$J,358.3,15260,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15260,1,4,0)
 ;;=4^339.22
 ;;^UTILITY(U,$J,358.3,15260,1,5,0)
 ;;=5^Headache,Post-Traumatic Chr
 ;;^UTILITY(U,$J,358.3,15260,2)
 ;;=^336554
 ;;^UTILITY(U,$J,358.3,15261,0)
 ;;=339.3^^81^941^47
 ;;^UTILITY(U,$J,358.3,15261,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15261,1,4,0)
 ;;=4^339.3
 ;;^UTILITY(U,$J,358.3,15261,1,5,0)
 ;;=5^Headache,Drug Induced
 ;;^UTILITY(U,$J,358.3,15261,2)
 ;;=^336555
 ;;^UTILITY(U,$J,358.3,15262,0)
 ;;=339.41^^81^941^63
 ;;^UTILITY(U,$J,358.3,15262,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15262,1,4,0)
 ;;=4^339.41
 ;;^UTILITY(U,$J,358.3,15262,1,5,0)
 ;;=5^Hemicrania Continua
 ;;^UTILITY(U,$J,358.3,15262,2)
 ;;=^336556
 ;;^UTILITY(U,$J,358.3,15263,0)
 ;;=339.42^^81^941^49
 ;;^UTILITY(U,$J,358.3,15263,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15263,1,4,0)
 ;;=4^339.42
 ;;^UTILITY(U,$J,358.3,15263,1,5,0)
 ;;=5^Headache,NDPH
 ;;^UTILITY(U,$J,358.3,15263,2)
 ;;=^336557
 ;;^UTILITY(U,$J,358.3,15264,0)
 ;;=339.43^^81^941^56
 ;;^UTILITY(U,$J,358.3,15264,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15264,1,4,0)
 ;;=4^339.43
 ;;^UTILITY(U,$J,358.3,15264,1,5,0)
 ;;=5^Headache,Primary Thunderclap
 ;;^UTILITY(U,$J,358.3,15264,2)
 ;;=^336558
 ;;^UTILITY(U,$J,358.3,15265,0)
 ;;=339.44^^81^941^46
 ;;^UTILITY(U,$J,358.3,15265,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15265,1,4,0)
 ;;=4^339.44
 ;;^UTILITY(U,$J,358.3,15265,1,5,0)
 ;;=5^Headache,Comp Syndrome
 ;;^UTILITY(U,$J,358.3,15265,2)
 ;;=^336559
 ;;^UTILITY(U,$J,358.3,15266,0)
 ;;=339.81^^81^941^48
 ;;^UTILITY(U,$J,358.3,15266,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI0VE
